Why ASX healthcare shares are a no-brainer for the 2020s

Here's why I think ASX healthcare shares like CSL Limited (ASX: CSL) are a no-brainer for 2020 investments.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

I would describe ASX healthcare shares as a somewhat 'under-the-radar' sector of the share market. Sure, market-darling CSL Limited (ASX: CSL) has managed to sneak up to be one of the most popular ASX shares to hold in a modern portfolio.

But out of the ASX 50 (that's the largest 50 Aussie public companies) – only 4 are classified as belonging to the healthcare industry.

They are CSL, Ramsay Health Care Limited (ASX: RHC), Sonic Healthcare Limited (ASX: SHL) and Cochlear Limited (ASX: COH).

If you were splitting hairs, you could also throw in Medibank Private Ltd (ASX: MPL), although it's technically a Financial.

But I think healthcare is one of the best places to be investing as we begin the new decade. In my view, the under-representation of healthcare in the ASX 50 just means there's plenty of room for growth!

Why?

Well, I have 2 rock-solid (in my opinion, anyway) reasons.

1. Ageing demographics

It's no secret that our population is ageing. According to reporting in the Sydney Morning Herald, it's estimated that by the year 2056, there is expected to be just 2 workers for every 1 retiree – down from today's ratio of 4-to-1.

That's a scary statistic, but it's also one that I think indicates a lot of potential in the healthcare sector for investing today.

2. Government support

As our population ages, there is going to inevitably be more pressure on government services to provide the same level of care from fewer taxes being proportionally paid by less workers. As a result, I expect governments to increasingly rely on the private sector to fill this gap.

This might come through the use of higher tax incentives like the private health insurance rebate and Medicare levy, or grants to private health providers to shoulder some of this burden.

Whichever way the cookie crumbles, I think this sector will stand to benefit as we stare down this barrel.

Yes, I think the government will be buying more vaccines from CSL as time goes on.

Yes, I think Ramsay Health Care (and its extensive network of private hospitals) will benefit in more than one way from government policy in the future.

And yes, I think Medibank and other private insurers will continue to be encouraged by the state to take some of the pressure off Medicare.

Foolish takeaway

All in all, healthcare is a sector that I believe is a no-brainer to be investing in this decade and beyond, for the reasons outlined above. By looking at the demographic trends that are hitting our population, it's really not too hard to imagine the benefits that are going to flow into the healthcare sector as a whole. It's a pie I certainly want a slice of!

Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. and CSL Ltd. The Motley Fool Australia has recommended Cochlear Ltd., Ramsay Health Care Limited, and Sonic Healthcare Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A doctor appears shocked as he looks through binoculars on a blue background.
Opinions

4DMedical shares crash 20% this week: Should investors cut their losses on the once-booming stock?

The shares are now down 6.61% for the year to date.

Read more »

A woman researcher holds a finger up in happiness as if making the 'number one' sign with a graphic of technological data and an orb emanating from her finger while fellow researchers work in the background.
Healthcare Shares

Top broker tips 57% upside for beaten-down Telix shares

A leading broker expects a big rebound in Telix shares in 2026.

Read more »

Research, collaboration and doctors working digital tablet, analysis and discussion of innovation cancer treatment. Healthcare, teamwork and planning by experts sharing idea and strategy for surgery.
Healthcare Shares

Here's why Anteris shares are in a trading halt today

The company is undertaking a US$300m capital raising.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Telix shares in focus as the company meets guidance

More good news from the drug developer.

Read more »

Doctor sees virtual images of the patient's x-rays on a blue background.
Healthcare Shares

What are the healthcare stocks where RBC Capital Markets thinks you can make money?

The top buys in the sector, listed.

Read more »

A sad looking scientist sitting and upset about a share price fall.
Healthcare Shares

Polynovo shares fall despite yesterday's upbeat update. Here's what investors are watching

Polynovo shares slide after a solid update as investors wait for clearer growth signals.

Read more »

Woman flexes muscles after donating blood.
Healthcare Shares

Check out this CSL share price forecast for 2026. It's hard to believe!

RBC Capital Markets thinks CSL is a bargain at current levels.

Read more »

Scientists working in the laboratory and examining results.
Healthcare Shares

Good news out of China has this drug company's shares higher

A major new market will open up following this approval.

Read more »